Literature DB >> 19721436

Rethinking therapeutic cancer vaccines.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19721436     DOI： 10.1038/nrd2994

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Therapeutic cancer vaccines.

Authors:  Fleur Pijpers; Richard Faint; Nish Saini
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694
  1 in total
  8 in total

Review 1.  Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.

Authors:  Hans-Georg Eichler; Eric Abadie; Alasdair Breckenridge; Bruno Flamion; Lars L Gustafsson; Hubert Leufkens; Malcolm Rowland; Christian K Schneider; Brigitte Bloechl-Daum
Journal:  Nat Rev Drug Discov       Date:  2011-07-01       Impact factor: 84.694

2.  Cancer immunotherapy meets biomaterials.

Authors:  Jeffrey S Weber; James J Mulé
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

3.  Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Authors:  Pawel Kalinski; Howard Edington; Herbert J Zeh; Hideho Okada; Lisa H Butterfield; John M Kirkwood; David L Bartlett
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 4.  Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.

Authors:  Pawel Kalinski; Hideho Okada
Journal:  Semin Immunol       Date:  2010-04-20       Impact factor: 11.130

Review 5.  Immunotherapy of cancer in 2012.

Authors:  John M Kirkwood; Lisa H Butterfield; Ahmad A Tarhini; Hassane Zarour; Pawel Kalinski; Soldano Ferrone
Journal:  CA Cancer J Clin       Date:  2012-05-10       Impact factor: 508.702

6.  ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway.

Authors:  Nicholas S Wilson; Becky Yang; Adriana Baz Morelli; Sandra Koernig; Annie Yang; Stefanie Loeser; Denise Airey; Larissa Provan; Phil Hass; Hal Braley; Suzana Couto; Debbie Drane; Jeff Boyle; Gabrielle T Belz; Avi Ashkenazi; Eugene Maraskovsky
Journal:  Immunol Cell Biol       Date:  2011-09-06       Impact factor: 5.126

Review 7.  The application of exosomes as a nanoscale cancer vaccine.

Authors:  Aaron Tan; Hugo De La Peña; Alexander M Seifalian
Journal:  Int J Nanomedicine       Date:  2010-11-10

8.  Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery.

Authors:  Ronnie H Fang; Che-Ming J Hu; Brian T Luk; Weiwei Gao; Jonathan A Copp; Yiyin Tai; Derek E O'Connor; Liangfang Zhang
Journal:  Nano Lett       Date:  2014-03-28       Impact factor: 11.189
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.